Showing results (81-90 of 141) with videos related to
Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Randomized phase III trial comparing the new potent and selective third-generation aromatase inhibitor vorozole with megestrol acetate in postmenopausal advanced breast cancer patients. North American Vorozole Study GroupP E Goss, E P Winer, I F Tannock, et al.Journal of Clinical Epidemiology|February 25, 1998
Responsiveness to change in health-related quality of life in a randomized clinical trial: a comparison of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) with analogous scales from the EORTC QLQ-C30 and a trial specific module. European Organization for Research and Treatment of CancerM R Stockler, D Osoba, P Goodwin, et al.American Journal of Clinical Oncology|April 1, 1993
Phase II multicenter study of epirubicin for hormone-resistant prostatic cancer with measurable soft tissue diseaseI F Tannock, T J Erwin, D J Stewart, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 11, 2013
Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancerF E Vera-Badillo, R Shapiro, A Ocana, et al.British Journal of Cancer|March 23, 2006
Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapyJ Vardy, K S Chiew, J Galica, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000
Cognitive function in breast cancer patients receiving adjuvant chemotherapyC B Brezden, K A Phillips, M Abdolell, et al.Prostate Cancer and Prostatic Diseases|June 25, 2008
The relationship of body mass index and serum testosterone with disease outcomes in men with castration-resistant metastatic prostate cancerA J Armstrong, S Halabi, R de Wit, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2007
Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshopJ Vardy, J S Wefel, T Ahles, et al.Journal of Clinical Epidemiology|July 3, 1999
Convergent discriminitive, and predictive validity of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) assessment and comparison with analogous scales from the EORTC QLQ-C30 and a trial-specific module. European Organisation for Research and Treatment of Cancer. Core Quality of Life QuestionnaireM R Stockler, D Osoba, P Corey, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 1997
Gemcitabine: a promising new agent in the treatment of advanced urothelial cancerM J Moore, I F Tannock, D S Ernst, et al.Pageof 15